Watkins Thomas
- SEC CIK
- 0001307935
No open-market purchases or sales filed in the past year.
Current role at each company
- HZNP Horizon Therapeutics Public Ltd CoDirectoras of Oct 6, 2023
- VNDA Vanda Pharmaceuticals Inc.Directoras of Jun 3, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Watkins Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VNDA Vanda Pharmaceuticals Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2022 (view filing) | Jun 2 | 1 day | Watkins ThomasDirector | SSale | −6.44K | $9.90 | −$63.8K | −9.3%63.1K after |